Officers
President
Richard (Rick) McKenna
Rick has spent 25 years coaching executives and creating branding and marketing programs for more than 200 companies of every size. His firm Atlantic Strategies works with entrepreneurial-led companies of any size in healthcare, financial services, technology, consumer products and higher education. Current clients include GE Healthcare, PKF O’Connor Davies, Meach Cove Capital and 270 Surgical. Rick spends a good portion of his time acting as a “trusted advisor” to international executives to guide them on efficiently entering the US through cultural immersion, key contact networking, branding, and on all aspects of digital and traditional marketing. His mobile app business, Manage My Things, helps homeowners create and securely share photo-based inventories of all their things for estate planning, insurance, downsizing and charitable donations.
Vice President
Mike Fisher
Mike is Vice President and Board member of BABCNE and leads the organisations activities in the life sciences.
Mike has a PhD in medicinal chemistry and 28 years’ experience of life sciences business development, commercialisation, project management and government relations. He has worked in both the public and private sectors, focusing on biotech business development for the past 16 years.
Mike joined Oncimmune in 2017 and drove the adoption strategy for EarlyCDT Lung in the UK/Europe and Oncimmune’s move into precision medicine services. Following the sale of the early cancer detection business in 2023, Mike rebuilt Oncimmune’s Commercial Team and relocated the BD office to Boston MA, USA where he is now based. Mike joined Oncimmune from Abcodia, where he was Director of Strategic Alliances, focusing on biomarker validation for early detection of cancer and other diseases.
Before this he was Business Development Director for Bio Nano Consulting, a spin-out from University College London and Imperial College.
Between 2005 and 2008, Mike was the UK government’s Life Sciences Industry Advisor for North America, based in Cambridge MA, where he liaised between US corporates and the UK Department of Health, NICE and MHRA.
Prior to moving to the US Mike worked in life science economic development in the public sector and provided internationalisation consultancy to life science companies. Mike performed his post-doctoral research at DSTL Porton Down, developing detection systems for toxins and pathogens, where he became the Project Manager for their Blue Sky research programmes in biological detection.
In addition, Mike is the founder of the Boston Biotech Brits, a member of the Advisory Board of BioPartner UK and the European Producer for TechNation and BiotechNation on National Public Radio.
Treasurer
Jane Ollerhead
Clerk
E. Barlow Keener
